Update from a 12-Year Nationwide Fungemia Surveillance: Increasing Intrinsic and Acquired Resistance Causes Concern
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
New data from the years 2012 to 2015 from the Danish National Fungemia Surveillance are reported, and epidemiological trends are investigated in a 12-year perspective (2004 to 2015). During 2012 to 2015, 1,900 of 1,939 (98%) fungal bloodstream isolates were included. The average incidence was 8.4/100,000 inhabitants, and this appears to represent a stabilizing trend after the increase to 10.1/100,000 in 2011. The incidence was higher in males than females (10.0 versus 6.8) and in patients above 50 years, and those changes were mainly driven by an increasing incidence among 80-to-89-year-old males (65.3/100,000 in 2014 to 2015). The proportion of Candida albicans isolates decreased from 2004 to 2015 (64.4% to 42.4%) in parallel with a doubling of the proportion of Candida glabrata isolates (16.5% to 34.6%,P< 0.0001).C. glabrata was more common among females (34.0% versus 30.4% in males). Following an increase in 2004 to 2011, the annual drug use stabilized during the last 2 to 3 years of that time period but remained higher than in other Nordic countries. This was particularly true for the fluconazole and itraconazole use in the primary health care sector, which exceeded the combined national levels of use of these compounds in each of the other Nordic countries. Fluconazole susceptibility decreased (68.5%, 65.2%, and 60.6% in 2004 to 2007, 2008 to 2011, and 2012 to 2015, respectively,P< 0.0001), and echinocandin resistance emerged in Candida(0%, 0.6%, and 1.7%, respectively,P< 0.001). Amphotericin B susceptibility remained high (98.7%). Among 16 (2.7%) echinocandin-resistant C. glabrata isolates (2012 to 2015), 13 harbored FKS mutations and 5 (31%) were multidrug resistant. The epidemiological changes and the increased incidence of intrinsic and acquired resistance emphasize the importance of continued surveillance and of strengthened focus on antifungal stewardship.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
Morrell, M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3640-3645.2005 · Cited by 1,286
Cornely, O. A., Bassetti, M., Calandra, T., Garbino, J., Kullberg, B. J., Lortholary, O., Meersseman, W., Akova, M., Arendrup, M. C., Arikan-Akdagli, S., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12039 · Cited by 1,217
Self-citationAlexander, B. D., Johnson, M. D., Pfeiffer, C. D., Jiménez-Ortigosa, C., Catania, J., Booker, R., Castanheira, M., Messer, S. A., Perlin, D. S., & Pfaller, M. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit136 · Cited by 778 · cited 1×
“glabrata, and 31% were fluconazole cross resistant, as reported elsewhere (31, 59, 60).”
BackgroundGlobal trends in the distribution of Candida species causing candidemia
Guinea, J. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12539 · Cited by 680
Hajjeh, R. A., Sofair, A. N., Harrison, L. H., Lyon, G. M., Arthington-Skaggs, B. A., Mirza, S. A., Phelan, M., Morgan, J., Lee-Yang, W., Ciblak, M. A., et al. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.4.1519-1527.2004 · Cited by 649
Internet-Accessible DNA Sequence Database for Identifying Fusaria from Human and Animal Infections
O'Donnell, K., Sutton, D. A., Rinaldi, M. G., Sarver, B. A. J., Balajee, S. A., Schroers, H.-J., Summerbell, R. C., Robert, V. A. R. G., Crous, P. W., Zhang, N., et al. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.00989-10 · Cited by 633
Pfaller, M. A., Castanheira, M., Lockhart, S. R., Ahlquist, A. M., Messer, S. A., & Jones, R. N. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.06112-11 · Cited by 377
Lortholary, O., Desnos-Ollivier, M., Sitbon, K., Fontanet, A., Bretagne, S., & Dromer, F. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01128-10 · Cited by 362
Hope, W. W., Castagnola, E., Groll, A. H., Roilides, E., Akova, M., Arendrup, M. C., Arikan-Akdagli, S., Bassetti, M., Bille, J., Cornely, O. A., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12040 · Cited by 360
Self-citation
Research works printed but not linked: 1
- Lausch KR, Søgard M, Rosenvinge FS, Johansen HK, Boysen T, Røder BL, Mortensen KL, Nielsen L, Lemming LE, Olesen B, Leitz C, Kristensen L, Dzajic E, Østergård L, Schønheyder HC, Arendrup MC. 2017. Behind candidaemia: risk factors and outcome in a high-incidence nationwide setting, abstr OS0587. Abstr 27th ECCMID, 22 to 25 April 2017, Vienna, Austria.
Cited by
Items 101–129 of 129
Species Distribution and Antifungal Susceptibilities of Candida Species Isolated From Blood Culture
Cılo, B. D. (2023) · Cureus · doi:10.7759/cureus.38183 · Cited by 8
Synergistic In Vitro Interaction of Isavuconazole and Isoquercitrin against Candida glabrata
Schwarz, P., Nikolskiy, I., Dannaoui, É., Sommer, F., Bange, G., & Schwarz, P. (2022) · Journal of Fungi · doi:10.3390/jof8050525 · Cited by 6
Phosphatidylinositol 3-phosphate regulates iron transport via PI3P-binding CgPil1 protein
Askari, F., Vasavi, B., & Kaur, R. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112855 · Cited by 4
Luca, D. G. D., Alexander, D. C., Dingle, T. C., Dufresne, P. J., Fuller, J., German, G. J., Haldane, D. J. M., Hoang, L., Jiao, L., Kus, J. V., et al. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.01803-25 · Cited by 3
Turan, D., & Aksaray, S. (2022) · Mikrobiyoloji Bulteni · doi:10.5578/mb.20229709 · Cited by 5
Vera-Salazar, L. A., Hernández-Hernández, G., Gutiérrez‐Escobedo, G., Peñas, A. D. L., Castaño, I., & Castaño, I. (2025) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2025.104041 · Cited by 2
Rocha, V., Almeida, H., Sarmento, B. F. C. C., & das Neves, J. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17040460 · Cited by 2
Siopi, M., Alevra, A., Mitsopoulos, D., Pournaras, S., & Meletiadis, J. (2025) · Journal of Fungi · doi:10.3390/jof11090644 · Cited by 2
Zareshahrabadi, Z., Shafiekhani, M., Nikoupour, H., Nouraei, H., Morovati, H., & Zomorodian, K. (2021) · Case Reports in Transplantation · doi:10.1155/2021/9995583 · Cited by 2
Mechanisms of Resistance to Antifungal Agents
Perlin, D. S. (2023) · Wiley eBooks · doi:10.1002/9781683670438.mcm0134 · Cited by 2
Misawa, S., Chonan, M., Sano, M., Igawa, G., Takahashi, M., Ito, K., Nagasawa, T., Furusawa, K., Otsuka, S., Takeda, S., et al. (2025) · Medical Mycology Journal · doi:10.3314/mmj.25-00005 · Cited by 1
Buonafine, C. P., dos Santos, A., Favarello, L. M., Cognialli, R. C. R., Aquino, V. R., Mendes, A. V. A., Guimarães, T., Sukiennik, T., Carlesse, F., Castro, P. T. O., et al. (2026) · Mycoses · doi:10.1111/myc.70149 · Cited by 1
Siopi, M., Mitsopoulos, D., Alevra, A., Vargiami, M., Pournaras, S., & Meletiadis, J. (2026) · Journal of Fungi · doi:10.3390/jof12030187 · Cited by 1
Mechanisms of Resistance to Antifungal Agents
Perlin, D. S. (2023) · Wiley eBooks · doi:10.1002/9781683674849.mcm0134 · Cited by 1
Fraser, M. (2019) · UWE Research Repository (UWE Bristol)
Lepak, A. J., & Andes, D. R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819990-9.00018-4 · Cited by 2
New insights into the echinocandin resistance in Candida spp. in the clinical settingPreprint
Gedeon, A., Kalboussi, Y., Bigot, J., Le, V., Dannaoui, É., Vellaissamy, S., Antignac, M., Petrella, S., Hennequin, C., & Guitard, J. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.29.591739
Çil, M. K., Özlü, Ö., & Başaran, A. (2024) · Journal of Pediatric Infectious Diseases · doi:10.1055/s-0044-1789233
Meyahnwi, D., Siraw, B., & Reingold, A. L. (2022) · Figshare · doi:10.6084/m9.figshare.21547405
Rare yeast and resistance mechanisms
Hansen, A. P. (2019) · Digital Library of the University of Innsbruck (University of Innsbruck)
Fongémies : épidémiologie, diagnostic et conduite à tenir
Dellière, S., Chantelot, L., Garnaud, C., & Cornet, M. (2026) · EMC - Biologie Médicale · doi:10.1016/s2211-9698(25)48322-8
Bukari, A.-R. A., Sidney, B., & Gerstein, A. C. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.03.716392
Ćwiertnia, A., Chuchla, L., & Ociepa, T. (2026) · Pediatric Reports · doi:10.3390/pediatric18020055
Campa, I. C., Studebaker, M. C., Henao‐Martínez, A. F., Kršák, M., & Chastain, D. B. (2026) · Medical Mycology · doi:10.1093/mmy/myag080
Nanomedicine in the Topical Management of Vulvovaginal Candidiasis: An Overview of In Vivo Data
Lima, A., & das Neves, J. (2026) · Journal of Fungi · doi:10.3390/jof12080562
Gupta, A. K., Teasell, E. M., Pellegrino, G. M., Economopoulos, V., & Saunte, D. M. L. (2026) · Apmis · doi:10.1111/apm.70269
Changes in age composition and epidemiology of candidaemia, Iceland, 2012 to 2023
Ásmundsdóttir, L. R., Bergthorsdottir, J. G., Steinarsson, A. O., & Gottfreðsson, M. (2026) · Eurosurveillance · doi:10.2807/1560-7917.es.2026.31.40.2600120
Metadata
- Authors
- Astvad, K. M. T., Johansen, H. K., Røder, B. L., Rosenvinge, F. S., Knudsen, J. D., Lemming, L., Schønheyder, H. C., Hare, R. K., Kristensen, L., Nielsen, L., Gertsen, J. B., Dzajic, E., Pedersen, M., Østergård, C., Olesen, B., Søndergaard, T. S., & Arendrup, M. C.
- Affiliations
- Statens Serum Institut (DK)
- University of Copenhagen (DK)
- Slagelse Hospital (DK)
- Odense University Hospital (DK)
- Hvidovre Hospital (DK)
- Aarhus University Hospital (DK)
- Aalborg University Hospital (DK)
- Hospital South West Jutland (DK)
- Department of Clinical Microbiology, Lillebaelt Hospital, Vejle, Denmark
- Sygehus Sønderjylland (DK)
- ORCID
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2018-04
- Volume
- 56
- Issue
- 4
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- PMC
- PMC5869841
- OpenAlex
- W2773217499
- Cited by
- 125
- References
- 62
- Citations by year
- 2026: 7 · 2025: 7 · 2024: 12 · 2023: 12 · 2022: 19 · 2021: 20 · 2020: 18 · 2019: 16 · 2018: 14
- FWCI
- 10.10
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Clinical Microbiology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- VBN Forskningsportal (Aalborg Universitet) (publishedVersion, other-oa)
- PubMed (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion, cc-by)
- Funders
- Pfizer
- Gilead Sciences
- Cidara Therapeutics
- Amplyx
- Novo Nordisk
- Astellas Pharma
- Novo Nordisk Fonden (NNF12OC1015920)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Keywords
- fungemia, antifungal resistance, Candida glabrata, Candida albicans, fluconazole resistance, echinocandin resistance, amphotericin B susceptibility, epidemiological trends, incidence, Denmark, Nordic countries, surveillance data, itraconazole
- MeSH terms
- Age Factors, Aged, Aged, 80 and over, Amphotericin B, Antifungal Agents, Candida, Candida albicans, Denmark, Female, Humans, Male, Microbial Sensitivity Tests, Middle Aged, Sex Factors, Fluconazole, Incidence, Fungemia, Itraconazole, Drug Resistance, Multiple, Fungal, Candida glabrata, Echinocandins, Epidemiological Monitoring
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.